Indivior Appoints New Chief Medical Officer

Ticker: INDV · Form: 8-K · Filed: Aug 22, 2025 · CIK: 1625297

Sentiment: neutral

Topics: executive-appointment, compensation

TL;DR

Indivior names new CMO, Christian Angel, with $450K salary + bonus + $1M equity.

AI Summary

On August 20, 2025, Indivior PLC announced the appointment of Dr. Christian Angel as Chief Medical Officer, effective September 1, 2025. Dr. Angel will receive an annual base salary of $450,000, a target annual bonus of 50% of his base salary, and an equity award with a target grant date fair value of $1,000,000. He will also receive a sign-on bonus of $100,000, payable within 30 days of his start date.

Why It Matters

The appointment of a new Chief Medical Officer is a key leadership change that could impact the company's strategic direction in medical affairs and drug development.

Risk Assessment

Risk Level: low — This filing primarily concerns an executive appointment and compensation, which typically carries a low inherent risk.

Key Numbers

Key Players & Entities

FAQ

Who has been appointed as the new Chief Medical Officer for Indivior PLC?

Dr. Christian Angel has been appointed as the new Chief Medical Officer for Indivior PLC.

When is Dr. Christian Angel's appointment as Chief Medical Officer effective?

Dr. Christian Angel's appointment is effective September 1, 2025.

What is Dr. Christian Angel's annual base salary?

Dr. Christian Angel's annual base salary is $450,000.

What is the target annual bonus for Dr. Christian Angel?

The target annual bonus for Dr. Christian Angel is 50% of his base salary.

What is the value of the equity award granted to Dr. Christian Angel?

The equity award granted to Dr. Christian Angel has a target grant date fair value of $1,000,000.

Filing Stats: 645 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2025-08-22 16:58:37

Key Financial Figures

Filing Documents

01 Exhibits

Item 9.01 Exhibits (d) Exhibits. Exhibit No. Description 10.1 Employment Agreement dated as of January 1, 2025 by Indivior, Inc. and Ryan Preblick. 10.2 Confidentiality, Proprietary Rights and Non-Competition Agreement entered into as of January 1, 2025 by Indivior, Inc. and Ryan Preblick. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Indivior PLC Date: August 22, 2025 By: /s/ Jeff Burris Name: Jeff Burris Title: Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing